Transgelin interacts with PARP1 in human colon cancer cells

[1]  M. Kassem,et al.  Transgelin is a poor prognostic factor associated with advanced colorectal cancer (CRC) stage promoting tumor growth and migration in a TGFβ-dependent manner , 2020, Cell Death & Disease.

[2]  Wen-Jeng Wu,et al.  Transgelin in bladder cancer: A potential biomarker and therapeutic target , 2019, EBioMedicine.

[3]  Ruoxi Wang,et al.  The Role of PARPs in Inflammation—And Metabolic—Related Diseases: Molecular Mechanisms and Beyond , 2019, Cells.

[4]  J. Blay,et al.  PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target , 2019, Molecular oncology.

[5]  E. Rouchka,et al.  Coupling of PARP1-mediated chromatin structural changes to transcriptional RNA polymerase II elongation and cotranscriptional splicing , 2019, Epigenetics & Chromatin.

[6]  L. Virág,et al.  PARP1‐LSD1 functional interplay controls transcription of SOD2 that protects human pro‐inflammatory macrophages from death under an oxidative condition , 2019, Free radical biology & medicine.

[7]  Qiaojun He,et al.  PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3 , 2018, Cancer Immunology Research.

[8]  The UniProt Consortium,et al.  UniProt: a worldwide hub of protein knowledge , 2018, Nucleic Acids Res..

[9]  Yanqing Zhang,et al.  PARP1 promote autophagy in cardiomyocytes via modulating FoxO3a transcription , 2018, Cell Death & Disease.

[10]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[11]  B. Chait,et al.  Nuclear Arp2/3 drives DNA break clustering for homology-directed repair , 2018, Nature.

[12]  A. Waisman,et al.  PARP-1 protects against colorectal tumor induction, but promotes inflammation-driven colorectal tumor progression , 2018, Proceedings of the National Academy of Sciences.

[13]  Ying Lin,et al.  Functions of nuclear actin-binding proteins in human cancer. , 2017, Oncology letters.

[14]  Hui Xu,et al.  An analysis of the gene interaction networks identifying the role of PARP1 in metastasis of non-small cell lung cancer , 2017, Oncotarget.

[15]  A. Gingras,et al.  Plk4 Promotes Cancer Invasion and Metastasis through Arp2/3 Complex Regulation of the Actin Cytoskeleton. , 2017, Cancer research.

[16]  A. R. Gani,et al.  The PARP family: insights into functional aspects of poly (ADP‐ribose) polymerase‐1 in cell growth and survival , 2016, Cell proliferation.

[17]  Lai Xu,et al.  Quantitative proteomics reveals that distant recurrence-associated protein R-Ras and Transgelin predict post-surgical survival in patients with Stage III colorectal cancer , 2016, Oncotarget.

[18]  Ying Lin,et al.  AKT and JNK Signaling Pathways Increase the Metastatic Potential of Colorectal Cancer Cells by Altering Transgelin Expression , 2016, Digestive Diseases and Sciences.

[19]  J. Lee,et al.  Transgelin increases metastatic potential of colorectal cancer cells in vivo and alters expression of genes involved in cell motility , 2016, BMC Cancer.

[20]  Christopher M. Fife,et al.  Movers and shakers: cell cytoskeleton in cancer metastasis , 2014, British journal of pharmacology.

[21]  Davide Heller,et al.  STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..

[22]  J. Dennis,et al.  A novel role for Plk4 in regulating cell spreading and motility , 2014, Oncogene.

[23]  L. Zhang,et al.  Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis , 2014, British Journal of Cancer.

[24]  M. Shalaby,et al.  Novel mutations of the PARP-1 gene associated with colorectal cancer in the Saudi population. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[25]  P. Taimen,et al.  Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis. , 2014, The Journal of clinical investigation.

[26]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[27]  M. Berchtold,et al.  The many faces of calmodulin in cell proliferation, programmed cell death, autophagy, and cancer. , 2014, Biochimica et biophysica acta.

[28]  Adam J Pawson,et al.  The Concise Guide to Pharmacology 2013/14: Enzymes , 2013, British journal of pharmacology.

[29]  G. Melino,et al.  Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB , 2013, Oncotarget.

[30]  Alan Hall,et al.  Rho family GTPases. , 2012, Biochemical Society transactions.

[31]  N. Rahimi,et al.  Identification of IGPR-1 as a novel adhesion molecule involved in angiogenesis , 2012, Molecular biology of the cell.

[32]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[33]  Chan‐Wha Kim,et al.  Transgelin promotes migration and invasion of cancer stem cells. , 2010, Journal of proteome research.

[34]  F. Candotti,et al.  Nuclear Role of WASp in the Pathogenesis of Dysregulated TH1 Immunity in Human Wiskott-Aldrich Syndrome , 2010, Science Translational Medicine.

[35]  R. Karlsson,et al.  Rho GTPase function in tumorigenesis. , 2009, Biochimica et biophysica acta.

[36]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[37]  P. Buckhaults,et al.  Association of the actin-binding protein transgelin with lymph node metastasis in human colorectal cancer. , 2009, Neoplasia.

[38]  M. Tomita,et al.  Systematic identification of cell cycle-dependent yeast nucleocytoplasmic shuttling proteins by prediction of composite motifs , 2009, Proceedings of the National Academy of Sciences.

[39]  Xiao Lin,et al.  Poly(ADP-Ribose) Polymerase Inhibition Down-Regulates Expression of Metastasis-Related Genes in CT26 Colon Carcinoma Cells , 2009, Pathobiology.

[40]  Mei Han,et al.  Nuclear actin and actin‐binding proteins in the regulation of transcription and gene expression , 2009, The FEBS journal.

[41]  S. Assinder,et al.  Transgelin: an actin-binding protein and tumour suppressor. , 2009, The international journal of biochemistry & cell biology.

[42]  Mei Han,et al.  Human heart LIM protein activates atrial-natriuretic-factor gene expression by interacting with the cardiac-restricted transcription factor Nkx2.5. , 2008, The Biochemical journal.

[43]  Hiroyuki Yamamoto,et al.  Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis. , 2006, European journal of cancer.

[44]  Alan Hall,et al.  Rho GTPases: biochemistry and biology. , 2005, Annual review of cell and developmental biology.

[45]  Mei Han,et al.  hhLIM protein is involved in cardiac hypertrophy. , 2004, Biochimica et biophysica acta.

[46]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[47]  J. McConville,et al.  Mutagenesis analysis of human SM22: characterization of actin binding. , 2000, Journal of applied physiology.

[48]  S. Snyder,et al.  Poly(ADP-ribose) Polymerase-1 in the Nervous System , 2000, Neurobiology of Disease.

[49]  A. Means,et al.  Calmodulin: a prototypical calcium sensor. , 2000, Trends in cell biology.

[50]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..